N/A
Completed N=18
Resilience Measurement in Older Adults With Late-Stage Lung Cancer
Lung Cancer Stage III · Lung Cancer Stage IV
Source: ClinicalTrials.gov NCT04825912 ↗
Enrolled (actual)
18
Serious AEs
0.0%
Results posted
Feb 2024
Primary outcomePrimary: Confidence in Behavior as Measured by the Cancer Behavior Inventory — 80.89; 85.92; 93.23 score on a scale
Summary
The purpose of this study to test measures of physical and psychological resilience while using Self-System therapy (SST), to treat depression and lung-cancer-related distress in older adults (65 years and older).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Confidence in Behavior as Measured by the Cancer Behavior Inventory |
80.89; 85.92; 93.23 | — |
| SECONDARY Coping Skills Related to Stress as Measured by the Brief COPE (Coping Orientation to Problems Experienced) |
55.72; 58.54; 57.62 | — |
| SECONDARY Resilience as Measured by the CD-RISC-25 (Connor-Davidson Resilience Scale) |
73.16; 75.69; 78.00 | — |
| SECONDARY Depression as Measured by the Beck Depression Inventory (BDI-II) |
9.06; 7.92; 8.23 | — |
| SECONDARY Positive Affect as Measured by the PANAS (Positive and Negative Scale) |
32.72; 34.61; 36.15 | — |
| SECONDARY Negative Affect as Measured by the PANAS (Positive and Negative Scale) |
18.04; 17.31; 17.54 | — |
| SECONDARY Physical Activity as Measured by the PASE (Physical Activity Scale for the Elderly) |
101.06; 110.23; 109.17 | — |
| SECONDARY Pain Interference as Measured by the PROMIS PI (Patient-Reported Outcomes Measurement Information System Pain Interference) |
— | — |
| SECONDARY Number of Participants Who Completed the QUALE (Quality of Life at the End of Life) |
18; 13; 13 | — |
Eligibility Criteria
Inclusion Criteria
- Age 65 or older
- English-speaking
- The patient has a diagnosis of late-stage (III-IV) lung cancer and is living at his/her home.
Exclusion Criteria
- Unable to provide informed consent
- Visual or hearing impairments that preclude participation
- Serious mental illness
Data sourced from ClinicalTrials.gov (NCT04825912). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.